Acadian Asset Management Portfolio holdings
AUM
$48.4B
1-Year Return
32.04%
This Quarter Return
+8.62%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$32.2B
AUM Growth
-$282M
(-0.87%)
Cap. Flow
-$1.8B
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
2,410
New
656
Increased
561
Reduced
741
Closed
336
Top Buys
| 1 |
Ericsson
ERIC
|
+$303M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$264M |
| 3 |
Citigroup
C
|
+$196M |
| 4 |
Fortinet
FTNT
|
+$162M |
| 5 |
Infosys
INFY
|
+$144M |
Top Sells
| 1 |
Pinduoduo
PDD
|
+$419M |
| 2 |
NVIDIA
NVDA
|
+$417M |
| 3 |
Amazon
AMZN
|
+$388M |
| 4 |
Meta Platforms (Facebook)
META
|
+$288M |
| 5 |
CRH
CRH
|
+$272M |
Sector Composition
| 1 | Technology | 34.81% |
| 2 | Financials | 16.08% |
| 3 | Communication Services | 9.48% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
AmeriServ Financial
ASRV
$46.7M
| $65K | ﹤0.01% |
25,700
-7,800
| -23% | -$19.7K |
|
1727
National Beverage
FIZZ
$3.68B
| $65K | ﹤0.01% |
+1,393
| New | +$65K |
|
1728
Innodata
INOD
$1.85B
| $65K | ﹤0.01% |
+3,897
| New | +$65K |
|
1729
Lemonade
LMND
$3.63B
| $65K | ﹤0.01% |
+3,990
| New | +$65K |
|
1730
Rocket Pharmaceuticals
RCKT
$343M
| $65K | ﹤0.01% |
+3,553
| New | +$65K |
|
1731
United Maritime
USEA
$15.6M
| $65K | ﹤0.01% |
25,398
| – | – |
|
1732
Vulcan Materials
VMC
$38.9B
| $65K | ﹤0.01% |
260
-14,762
| -98% | -$3.69M |
|
1733
PACS Group
PACS
$1.2B
| $65K | ﹤0.01% |
+1,638
| New | +$65K |
|
1734
Ares Management
ARES
$39.3B
| $64K | ﹤0.01% |
415
-45
| -10% | -$6.94K |
|
1735
Aurinia Pharmaceuticals
AUPH
$1.61B
| $64K | ﹤0.01% |
+8,732
| New | +$64K |
|
1736
Cognition Therapeutics
CGTX
$221M
| $64K | ﹤0.01% |
+140,943
| New | +$64K |
|
1737
Nicolet Bankshares
NIC
$2B
| $64K | ﹤0.01% |
+679
| New | +$64K |
|
1738
Gibraltar Industries
ROCK
$1.79B
| $64K | ﹤0.01% |
917
-5,582
| -86% | -$390K |
|
1739
Acadia Pharmaceuticals
ACAD
$4.02B
| $63K | ﹤0.01% |
4,156
-2,728
| -40% | -$41.4K |
|
1740
IO Biotech
IOBT
$117M
| $63K | ﹤0.01% |
+60,650
| New | +$63K |
|
1741
The Bancorp
TBBK
$3.5B
| $63K | ﹤0.01% |
+1,194
| New | +$63K |
|
|
PWSC
1742
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $63K | ﹤0.01% |
+2,763
| New | +$63K |
|
1743
Arcutis Biotherapeutics
ARQT
$2.11B
| $62K | ﹤0.01% |
6,680
-153,348
| -96% | -$1.42M |
|
1744
Culp
CULP
$59.2M
| $62K | ﹤0.01% |
9,700
-1,090
| -10% | -$6.97K |
|
1745
MGE Energy Inc
MGEE
$3.05B
| $62K | ﹤0.01% |
686
| – | – |
|
1746
XPEL
XPEL
$990M
| $62K | ﹤0.01% |
+1,446
| New | +$62K |
|
1747
Eastman Chemical
EMN
$7.47B
| $61K | ﹤0.01% |
553
-1,453
| -72% | -$160K |
|
1748
Sable Offshore Corp
SOC
$2.45B
| $61K | ﹤0.01% |
+2,619
| New | +$61K |
|
|
CBIO
1749
Crescent Biopharma, Inc. Common Stock
CBIO
$170M
| $59K | ﹤0.01% |
3,574
-1,774
| -33% | -$29.3K |
|
|
NTST
1750
NETSTREIT Corp
NTST
$1.75B
| $59K | ﹤0.01% |
+3,587
| New | +$59K |
|